Total reported value
$2.6B
Reporting period: 2023-06-30 · Number of holdings: 166
Tekla Capital Management LLC disclosed 166 holdings in its latest 13F filing for the period ending 2023-06-30, with total reported value of $2.6B and a quarterly turnover rate of 0.0%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "T"
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AMGN | Amgen INC | Stock-Healthcare | 5.36% | — | +10.90% | |
| 2 | JNJ | Johnson & Johnson | Stock-Healthcare | 4.68% | — | — | |
| 3 | GILD | Gilead Sciences INC | Stock-Healthcare | 4.63% | — | -1.67% | |
| 4 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 4.54% | — | +12.84% | |
| 5 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 4.38% | — | -3.72% | |
| 6 | LLY | Eli Lilly & Co | Stock-Healthcare | 3.92% | — | -26.15% | |
| 7 | UNH | Unitedhealth Group INC | Stock-Healthcare | 3.89% | — | -11.62% | |
| 8 | MRK | Merck & Co. INC. | Stock-Healthcare | 3.29% | — | +31.88% | |
| 9 | ABBV | Abbvie INC | Stock-Healthcare | 2.88% | — | +6.65% | |
| 10 | BIIB | Biogen INC | Stock-Healthcare | 2.76% | — | +2.91% | |
| 11 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 2.74% | — | -1.61% | |
| 12 | ILMN | Illumina INC | Stock-Healthcare | 2.47% | — | -3.19% | |
| 13 | ABT | Abbott Laboratories | Stock-Healthcare | 2.36% | — | -11.45% | |
| 14 | PFE | Pfizer INC | Stock-Healthcare | 2.33% | — | -8.48% | |
| 15 | TMO | Thermo Fisher Scientific INC | Stock-Healthcare | 2.02% | — | +5.64% | |
| 16 | ELV | Elevance Health INC | Stock-Healthcare | 1.98% | — | — | |
| 17 | MRNA | Moderna INC | Stock-Healthcare | 1.63% | — | +6.67% | |
| 18 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.39% | — | +16.22% | |
| 19 | DHR | Danaher CORP | Stock-Healthcare | 1.34% | — | +35.12% | |
| 20 | MDT | Medtronic plc | Stock-Healthcare | 1.19% | — | -0.03% | |
| 21 | IDXX | Idexx Laboratories INC | Stock-Healthcare | 1.15% | — | — | |
| 22 | DXCM | Dexcom INC | Stock-Healthcare | 1.15% | — | — | |
| 23 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 1.15% | — | -30.93% | |
| 24 | ISRG | Intuitive Surgical INC | Stock-Healthcare | 1.12% | — | -25.47% | |
| 25 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 1.06% | — | — | |
| 26 | CI | THE Cigna Group | Stock-Healthcare | 1.06% | — | -47.25% | |
| 27 | MCK | Mckesson CORP | Stock-Healthcare | 1.04% | — | -6.77% | |
| 28 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.00% | — | -25.77% | |
| 29 | HCA | Hca Healthcare INC | Stock-Healthcare | 0.98% | — | -7.10% | |
| 30 | SYK | Stryker CORP | Stock-Healthcare | 0.97% | — | +13.34% | |
| 31 | IQV | Iqvia Holdings INC | Stock-Healthcare | 0.96% | — | +72.90% | |
| 32 | ZTS | Zoetis INC | Stock-Healthcare | 0.92% | — | — | |
| 33 | CRL | Charles River Laboratories | Stock-Healthcare | 0.91% | — | -5.84% | |
| 34 | SGENUSD | Seagen INC | Stock-Other | 0.85% | — | -50.00% | |
| 35 | SRPT | Sarepta Therapeutics INC | Stock-Healthcare | 0.80% | — | -37.18% | |
| 36 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 0.78% | — | +10.29% | |
| 37 | ✓ | Oculis Holding AG | Stock-Other | 0.74% | — | — | |
| 38 | MOH | Molina Healthcare INC | Stock-Healthcare | 0.73% | — | — | |
| 39 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 0.72% | — | — | |
| 40 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 0.72% | — | -29.76% | |
| 41 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 0.70% | — | +10.78% | |
| 42 | HUM | Humana INC | Stock-Healthcare | 0.64% | — | — | |
| 43 | APLSUSD | Apellis Pharmaceuticals INC | Stock-Other | 0.62% | — | +28.21% | |
| 44 | BAX | Baxter International INC | Stock-Healthcare | 0.58% | — | +381.89% | |
| 45 | EXEL | Exelixis INC | Stock-Healthcare | 0.54% | — | — | |
| 46 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 0.54% | — | — | |
| 47 | ✓ | Stock-Other | 0.50% | — | +9.59% | ||
| 48 | PODD | Insulet CORP | Stock-Healthcare | 0.49% | — | — | |
| 49 | GH | Guardant Health INC | Stock-Healthcare | 0.48% | — | -26.71% | |
| 50 | ASND | Ascendis Pharma A/S | Stock-Other | 0.48% | — | +12.12% |
Performance for Q3 2026
+10.3%
Performance Last 4 Quarters
+25.7%
Based on 60% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2023-06-30 | 166 | $2.6B | 0 | |
| 2023-03-31 | 177 | $2.6B | 0 | |
| 2022-12-31 | 172 | $2.6B | 0 | |
| 2022-09-30 | 169 | $2.4B | 0 | |
| 2022-06-30 | 177 | $2.5B | 0 | |
| 2022-03-31 | 175 | $2.8B | 0 | |
| 2021-12-31 | 171 | $3.1B | 0 | |
| 2021-09-30 | 172 | $3.1B | 0 | |
| 2021-06-30 | 189 | $3.1B | 97 | |
| 2021-03-31 | 196 | $2.9B | 34 | |
| 2020-12-31 | 200 | $2.8B | 44 | |
| 2020-09-30 | 204 | $2.7B | 31 | |
| 2020-06-30 | 222 | $2.6B | 29 | |
| 2020-03-31 | 217 | $2.2B | 28 | |
| 2019-12-31 | 214 | $2.6B | 32 | |
| 2019-09-30 | 192 | $2.3B | 20 | |
| 2019-06-30 | 197 | $2.5B | 14 | |
| 2019-03-31 | 194 | $2.5B | 25 | |
| 2018-12-31 | 203 | $2.3B | 25 | |
| 2018-09-30 | 212 | $2.8B | 23 | |
| 2018-06-30 | 180 | $2.6B | 19 | |
| 2018-03-31 | 187 | $2.6B | 29 | |
| 2017-12-31 | 161 | $2.6B | 28 | |
| 2017-09-30 | 152 | $2.8B | 19 | |
| 2017-06-30 | 144 | $2.7B | 18 | |
| 2017-03-31 | 139 | $2.6B | 25 | |
| 2016-12-31 | 143 | $2.3B | 22 | |
| 2016-09-30 | 142 | $2.6B | 28 | |
| 2016-06-30 | 156 | $2.4B | 25 | |
| 2016-03-31 | 140 | $2.4B | 30 | |
| 2015-12-31 | 134 | $2.8B | 30 | |
| 2015-09-30 | 160 | $2.8B | 38 | |
| 2015-06-30 | 116 | $2.8B | 40 | |
| 2015-03-31 | 116 | $2.5B | 42 | |
| 2014-12-31 | 96 | $2.1B | 30 | |
| 2014-09-30 | 108 | $2.1B | 68 | |
| 2014-06-30 | 64 | $1.1B | 25 | |
| 2014-03-31 | 61 | $1.0B | 25 | |
| 2013-12-31 | 57 | $952.5M | 41 | |
| 2013-09-30 | 63 | $898.8M | 29 | |
| 2013-06-30 | 60 | $735.4M | 0 |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
Institutions with a similar AUM
CIK 0001586986
Total reported value
$2.6B
46 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001870364
Total reported value
$2.6B
574 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001591122
Total reported value
$2.6B
692 stks
2026-03-31
AUM within 0.2% of this institution
Institutions with overlapping top holdings
CIK 0000019481
Total reported value
$362.5M
450 stks
2026-03-31
4 of the top 5 holdings overlap, including Gilead Sciences INC
CIK 0001642343
Total reported value
$656.3M
127 stks
2015-12-31
Stale — no recent filing
3 of the top 5 holdings overlap, including Gilead Sciences INC
CIK 0001674546
Total reported value
$4.2B
167 stks
2026-03-31
3 of the top 5 holdings overlap, including Vertex Pharmaceuticals INC